House Oversight Subcmte. hearing on alleged FDA retaliation tentatively set for July 25.
This article was originally published in The Tan Sheet
Executive Summary
HOUSE OVERSIGHT SUBCOMMITTEE HEARING ON PERCEIVED FDA RETALIATION is tentatively set for July 25. The House Commerce/Over-sight Subcommittee hearing will focus on the belief that an adversarial relationship exists between FDA and the companies it regulates, with particular emphasis on allegations that the agency retaliates against its critics.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning